Clinical trials for cellular therapy products: conclusions reached by foreign regulatory bodies
Currently, the problem of adopting viable human cell-based drugs – biomedical cell products (BCPs) – in medical practice in the Russian Federation includes, among others, lack of experience in clinical trials for such drugs and insufficient expert assessment under the national state registration pro...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Russo |
| Опубліковано: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2020-07-01
|
| Серія: | Вестник трансплантологии и искусственных органов |
| Предмети: | |
| Онлайн доступ: | https://journal.transpl.ru/vtio/article/view/1195 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|